Study on Gender Differences in Acne Vulgaris Associated with Insulin Resistance:A Cross-Sectional Study

2021 ◽  
Author(s):  
Wenyao Mi ◽  
Xia Feng ◽  
Zheng-Qun Wang ◽  
Xin Ye ◽  
Hui-Ling Shu ◽  
...  
Keyword(s):  
Gender Differences ◽  
Sex Hormones ◽  
Plasma Glucose ◽  
Acne Vulgaris ◽  
Sex Hormone ◽  
The Body ◽  
Insulin Levels ◽  
Female Patients ◽  
Significant Difference ◽  
Male Patients

Abstract Objective The present study investigated the clinical characteristics and gender differences of acne vulgaris associated with insulin resistance (IR).Methods The present study was conducted in 100 patients, comprising 52 males and 48 females, having acne vulgaris. Of the total, 18 male patients and 9 female patients exhibited IR, whereas 34 male patients and 39 female patients exhibited non-IR (NIR). The height, weight, acne grade, sex hormone, lipid metabolism, plasma glucose, and insulin levels of all the patients were measured and statistically analyzed.Results In the male group, the body mass index of the group with IR was significantly higher than that of the group with NIR (P < 0.05). No significant difference was observed in the sex hormones and insulin-like growth factor-1 (IGF-1) between female patients having acne associated with IR and those having acne associated with NIR. Levels of testosterone and sex hormone-binding globulin in male patients having acne associated with IR were lower than those in patients having acne associated with NIR, whereas the estrogen and IGF-1 levels in male patients with acne in the IR group were higher than those in the NIR group. Significant differences were observed in the fasting plasma glucose and fasting and 2-h postprandial plasma insulin levels between male and female groups (P < 0.05).Conclusion Disorders of sex hormone in male patients with acne vulgaris are related to IR; however, this correlation is not significant in women. Levels of sex hormones and metabolism in male patients having acne associated with IR must be actively monitored, and appropriate intervention must be administered.

Clinical Outcomes for “Suspicious” Category in Thyroid Fine-Needle Aspiration Biopsy: Patient's Sex and Nodule Size Are Possible Predictors of Malignancy

2009 ◽  
Vol 133 (5) ◽  
pp. 787-790
Author(s):  
Kirtee Raparia ◽  
Soo Kee Min ◽  
Dina R. Mody ◽  
Rose Anton ◽  
Mojgan Amrikachi
Keyword(s):  
Surgical Resection ◽  
Fine Needle Aspiration ◽  
Needle Aspiration ◽  
Cytologic Diagnosis ◽  
Fine Needle ◽  
Female Patients ◽  
Hürthle Cell ◽  
Significant Difference ◽  
Cell Neoplasm ◽  
Male Patients

Abstract Context.—Fine-needle aspiration (FNA) is recommended as an initial screening tool for the diagnosis of thyroid nodules. Approximately 10% of thyroid FNA diagnoses are “suspicious for neoplasm,” warranting surgical resection. Objectives.—To examine the role of a patient's age, sex, size of nodule, and morphologic features as possible predictors of malignancy in patients with cytologic diagnosis of “suspicious for neoplasm.” Design.—Cytopathology slides and reports of 402 consecutive thyroid FNAs from 2000–2005 interpreted as “suspicious” were reviewed. Of these, 180 cases that had subsequent surgical resection were selected. Results.—Of the 108 cases suspicious for follicular neoplasm on cytologic evaluation, histologic follow-up showed malignancy in 26 (24%). Of the 37 cases suspicious for Hürthle cell neoplasm, 15 (41%) had malignancy. Of the 35 cases suspicious for malignancy, 29 had malignant histologic diagnoses. Among cases with cytologic diagnoses of “suspicious for follicular or Hürthle cell neoplasm,” the rate of malignancy in female patients was 22% as compared to 43% in male patients (P = .02). The rate of malignancy in nodules less than 2 cm was 19% compared to 47% in nodules measuring 2 cm or larger (P &lt; .001). These differences were statistically significant. No statistically significant difference was noted between the age of the patient and the rate of benign versus malignant diagnosis. Conclusions.—Malignant tumors were more frequent in male patients with a cytologic diagnosis of “suspicious for follicular or Hürthle cell neoplasm” than in female patients. Risk of malignancy was higher in nodules measuring 2 cm or larger. Age of the patient was not a predictor of malignancy.

scholarly journals Gender and Quality of Life After Cerebral Stroke

2010 ◽  
Vol 10 (2) ◽  
pp. 94-99 ◽  
Author(s):  
Amra Zalihić ◽  
Vedran Markotić ◽  
Dino Zalihić ◽  
Mirela Mabić
Keyword(s):  
Quality Of Life ◽  
Life Quality ◽  
Female Gender ◽  
Cerebral Stroke ◽  
Female Patients ◽  
Negative Prognostic Factor ◽  
Significant Difference ◽  
Medium Range ◽  
Male Patients

The aim of this work is to investigate the influence of gender on recovery after cerebral stroke.It is believed that functional outcome of cerebral stroke (CS) depends on gender. Female gender is mildly negative prognostic factor in after stroke results. Two hundred and two patients who had first ischemic cerebral stroke were questioned with help of, HADS and WHOQOL-Bref questionnaires, looking for differences in recovery depending on gender. Average patients' age was 72+/-13 (ME+/-IR) years. The youngest patient had 40 years, and the oldest 92 years, and medium range was 52 years. There were 112 males and 90 females. Quality of life was equally graded by both male and female after CS (p=0.208). Male patients had significantly better results in physical (p=0.035) and psychological (p=0.020) domain of life quality. After CS, male patients had better results only in memory dimension (p=0.003). Anxiety was statistically more frequent among female patients (p=0.009). Gender did not influence frequency of metabolic syndrome in patients with CS. Quality of life after CS was better in male patients, and statistically significant difference has been shown in physical, psychological domain and memory dimension. Female patients were more anxious then male after CS.

Prisoners of XYY Constitution: Biochemical Studies

1972 ◽  
Vol 121 (563) ◽  
pp. 365-368 ◽  
Author(s):  
A. W. Griffiths ◽  
V. Marks ◽  
D. Fry ◽  
G. Morley ◽  
Gillian Lewis
Keyword(s):  
General Population ◽  
Sex Hormones ◽  
Psychiatric Hospitals ◽  
The Body ◽  
Plasma Testosterone ◽  
Testosterone Levels ◽  
Maximum Security ◽  
Significant Difference ◽  
Biochemical Studies ◽  
Psychopathic Disorder

The XYY constitution has achieved some measure of clinical definition, having been found in association with tallness, asocial personality, dilution of intelligence (Griffiths, 1971) and a tendency to psychopathic disorder (Griffiths, Richards, Zaremba, Abramowicz and Stewart, 1970). In addition, neurological, endocrinological, skeletal and other abnormalities have been reviewed (Griffiths, 1971), and the condition, like mongolism, has come to be regarded as affecting many systems of the body to a greater or lesser extent. Biochemical investigations, hitherto largely concerned with sex hormones, especially testosterone, have in general revealed no significant difference from matched controls. Some authors have, however, reported increased plasma testosterone levels both in 46 XY and 47 XYY patients of maximum security hospitals as compared to patients in other psychiatric hospitals and to the general population (Ismail, Harkness, Kirkham, Loraine, Whatmore and Brittain, 1968; Rudd, Galal and Casey, 1968; Price and Van de Molen, 1970). The pre-eminent desirability of rigorously selected controls has been remarked on in these investigations.

Probing the Impact of Gender-Affirming Hormone Treatment on Odor Perception

2019 ◽  
Vol 45 (1) ◽  
pp. 37-44 ◽  
Author(s):  
Georg S Kranz ◽  
Ulrike Kaufmann ◽  
Rupert Lanzenberger
Keyword(s):  
Sex Hormones ◽  
Hormone Treatment ◽  
Sex Hormone ◽  
Test Battery ◽  
Sex Hormone Binding Globulin ◽  
Odor Perception ◽  
Biological Sex ◽  
Transgender Persons ◽  
Significant Difference ◽  
The Impact

Abstract Evidence suggests that women outperform men in core aspects of odor perception, and sex hormones may play a significant role in moderating this effect. The gender-affirming treatment (GAT) of transgender persons constitutes a powerful natural experiment to study the psychological and behavioral effects of high dosages of cross-sex hormone applications. Therefore, our aim was to investigate the effects of GAT on odor perception in a sample of 131 participants including female and male controls, as well as transmen and transwomen over their first 4 months of gender transition. The Sniffin’ Sticks test battery was used to measure odor detection, discrimination, and identification at baseline, as well as 1 and 4 months after the start of GAT. Plasma levels of estradiol, testosterone, and sex hormone-binding globulin were analyzed for each assessment point. Results revealed no significant change of olfactory performance in the two transgender groups compared with female and male controls. There was no significant difference between groups at baseline or any other time point. Neither biological sex, nor gender identity had an influence on odor perception. Moreover, there was no significant correlation between sex hormones and odor perception and between GAT-induced changes in sex hormones and changes in odor perception. Our results indicate that the effects of sex hormones on olfactory performance are subtle, if present at all. However, our results do not preclude hormonal effects on odors not included in the Sniffin’ Sticks test battery, such as body odors or odors associated with sex.

scholarly journals Gender Differences of First Admitted Patients with Acute Psychotic Disorder

2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
A.-M. Murgulescu
Keyword(s):  
Gender Differences ◽  
Marital Status ◽  
Psychiatric Hospital ◽  
Psychotic Disorder ◽  
Employment Status ◽  
Clinical Characteristics ◽  
Age Of Onset ◽  
Female Patients ◽  
Male Patients ◽  
First Admission

Objective:The gender differences in aspect of sociodemographic and clinical characteristics have been analyzed in a sample of first admitted patients with acute psychotic disorder in an acute psychiatric hospital.Method:Retrospective sociodemographic and clinical data regarding first admitted patients diagnosed with acute psychotic disorder were gathered and analyzed.Results:Of all patients 52.7% were female and 47.3% were male. We analyzed gender differences in age of onset, marital status, education period, employment status, and time between onset of symptoms and admission in hospital. Female patients were older at their first admission than male patients, and more female patients were educated longer than male patients. Female patients tend to be married (30%) and employed (40%) at the time of their admission than male patients (11.1% married and 22.2% employed). the time between onset of symptoms and admission in hospital was longer for the majority of male patients (more than 1 year for 62.9% of men) than for the majority of female patients (0-3 months for 40% of women).Conclusions:There were gender differences in age of onset, marital status, education period, employment status, time between onset of symptoms and admission in hospital pointing to the role played by biopsychosocials factors in onset of acute psychotic disorder.

Subanalysis of the StiL NHL 1–2003 Study: Achievement of Complete Response with Bendamustine-Rituximab (B-R) and CHOP-R in the First-Line Treatment of Indolent and Mantle Cell Lymphomas Results in Superior Survival Compared to Partial Response.

Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 2724-2724 ◽  
Author(s):  
Mathias J. Rummel ◽  
Norbert Niederle ◽  
Georg Maschmeyer ◽  
G.-Andre Banat ◽  
Ulrich von Grünhagen ◽  
...  
Keyword(s):  
Complete Response ◽  
Line Treatment ◽  
First Line ◽  
Female Patients ◽  
Significant Difference ◽  
Mantle Cell ◽  
Male Patients ◽  
The Impact ◽  
First Line Treatment

Abstract Abstract 2724 Background: The NHL 1 study, a prospective, multicenter, randomized, phase 3 study which compared B-R and CHOP-R as first-line treatment in indolent lymphomas and mantle cell lymphoma (MCL), demonstrated a significant benefit in progression-free survival (PFS) as well as improved tolerability for B-R compared with CHOP-R. Here we present an analysis of the impact of response quality on outcome. Methods: 514 patients (pts) with indolent or MCL were randomized to receive B-R or CHOP-R for a maximum of 6 cycles. Results: The overall response rate in the 514 pts (261 B-R; 253 CHOP-R) was 92.7% and 91.3% in the B-R and CHOP-R arms, respectively (as presented at the last ASCO meeting, J Clin Oncol 30, 2012 (suppl; abstr 3). A complete response (CR) was observed in 39.8% in the B-R arm and in 30% in the CHOP-R arm (p=0.021). The achievement of CR was associated with a significantly prolonged PFS and overall survival (OS) (Table 1). Analysis by treatment arm revealed a trend for superior PFS and a significantly improved OS for patients achieving CR following treatment with B-R. In the CHOP-R arm, patients in CR had a significantly superior PFS compared to those in PR with a trend to superior OS. Regardless of the quality of response, PFS was superior with B-R versus CHOP-R: For patients in CR, the median PFS was not reached with B-R, whereas for CHOP-R it was 53.7 months (p=0.0204). In patients achieving PR, treatment with B-R resulted in a median PFS of 57.2 months, and this was 30.9 months with CHOP-R (p=0.0002). We noted a statistically significant difference in CR rates between male (n=272, median age 63 years) and female (n=242, median age 64 years) patients. The CR rate was 28.6% in male patients and 42.1% in female patients (p=0.0016). Female patients had a longer median PFS (51.4 months) compared to male patients (38.6 months), however, this difference was not statistically significant (p=0.0866). Conclusions: Patients in CR following first-line treatment in our study had a significantly longer PFS and OS compared to those achieving a PR. Therefore, our results strongly suggest an association between quality of response and outcome. Disclosures: No relevant conflicts of interest to declare.

scholarly journals Fasting Hyperglycemia Increases In-Hospital Mortality Risk in Nondiabetic Female Patients with Acute Myocardial Infarction: A Retrospective Study

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Guojing Luo ◽  
Hong Liu ◽  
Shunkui Luo ◽  
Fang Li ◽  
Minhong Su ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Retrospective Study ◽  
Mortality Rate ◽  
Hospital Mortality ◽  
Plasma Glucose ◽  
Independent Predictor ◽  
Diabetic Patients ◽  
Female Patients ◽  
Significant Difference

Previous studies had shown that elevated admission plasma glucose (APG) could increase mortality rate and serious complications of acute myocardial infarction (AMI), but whether fasting plasma glucose (FPG) had the same role remains controversial. In this retrospective study, 253 cases of AMI patients were divided into diabetic (n=87) and nondiabetic group (n=166). Our results showed that: compared with the nondiabetic patients, diabetic patients had higher APG, FPG, higher plasma triglyceride, higher rates of painless AMI (P<0.01), non-ST-segment elevation myocardial infarction (NSTEMI), and reinfraction (P<0.05). They also had lower high density lipoprotein cholesterol and rate of malignant arrhythmia, but in-hospital mortality rate did not differ significantly (P>0.05). While nondiabetic patients were subgrouped in terms of APG and FPG (cut points were 11.1 mmol/L and 7.0 mmol/L, resp.), the mortality rate had significant difference (P<0.01), whereas glucose level lost significance in diabetic group. Multivariate logistic regression analysis showed that FPG (OR: 2.014; 95% confidence interval: 1.296–3.131;p<0.01) but not APG was independent predictor of in-hospital mortality for nondiabetic patients. These results indicate that FPG can be an independent predictor for mortality in nondiabetic female patients with AMI.

scholarly journals Gender aspects in cardiooncology

2021 ◽  
Author(s):  
Anna Hohneck ◽  
Florian Custodis ◽  
Stephanie Rosenkaimer ◽  
Ralf Hofheinz ◽  
Sandra Maier ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Gender Differences ◽  
Vitamin D ◽  
Cancer Diagnosis ◽  
Cancer Susceptibility ◽  
Mortality Rates ◽  
Female Patients ◽  
Male Patients ◽  
Gender Aspects

Abstract Background Cardiooncology is a relatively new subspeciality, investigating the side effects of cytoreductive therapies on the cardiovascular (CV) system. Gender differences are well known in oncological and CV diseases, but are less elucidated in cardiooncological collectives. Methods Five hundred and fifty-one patients (278 male, 273 female) with diagnosed cancer who underwent regular cardiological surveillance were enrolled in the ‘MAnnheim Registry for CardioOncology’ and followed over a median of 41 (95% confidence interval: 40–43) months. Results Female patients were younger at the time of first cancer diagnosis [median 60 (range 50–70) vs. 66 (55–75), P = 0.0004], while the most common tumour was breast cancer (49.8%). Hyperlipidaemia was more often present in female patients (37% vs. 25%, P = 0.001). Male patients had a higher cancer susceptibility than female patients. They suffered more often from hypertension (51% vs. 67%, P = 0.0002) or diabetes (14% vs. 21%, P = 0.02) and revealed more often vitamin D deficiency [(U/l) median 26.0 (range 17–38) vs. 16 (9–25), P = 0.002] and anaemia [(g/dl) median 11.8 (range 10.4–12.9) vs. 11.7 (9.6–13.6), P = 0.51]. During follow-up, 140 patients died (male 77, female 63; P = 0.21). An increased mortality rate was observed in male patients (11.4% vs. 14%, P = 0.89), with even higher mortality rates of up to 18.9% vs. 7.7% (P = 0.02) considering tumours that can affect both sexes compared. Conclusions Although female patients were younger at the time of first cancer diagnosis, male patients had both higher cancer susceptibility and an increased mortality risk. Concomitant CV diseases were more common in male patients.

scholarly journals PARATHYROID HORMONE AND BIOCHEMICAL METABOLIC BONE MARKERS IN PATIENTS WITH β-THALASSEMIA MAJOR IN MISAN PROVINCE / IRAQ

2020 ◽  
Vol 17 (35) ◽  
pp. 65-72
Author(s):  
Noor AL-Huda Salah AL-ZUHAIRY ◽  
Zainab Abdul Jabbar Ridha AL-ALI
Keyword(s):  
Vitamin D ◽  
Alkaline Phosphatase ◽  
Thalassemia Major ◽  
Control Group ◽  
Female Patients ◽  
Metabolic Bone ◽  
Significant Difference ◽  
Calcium Phosphorus ◽  
Male Patients ◽  
Serum Pth

Beta-thalassemia is a heterogeneous group of hereditary blood disorders characterized by defects in the synthesis of the β- chains of hemoglobin, resulting in variable phenotypes ranging from severe anemia to clinically asymptomatic individuals. This study aims to assess the serum PTH, vitamin D, calcium, phosphorus, alkaline phosphatase, and magnesium levels in β-thalassemia major patients. A total of 50 (30 male and 20 female) patients with β- thalassemia major with ages range 11- 16 years and an equal number of sex-matched healthy adolescents as a control group were included in this study. A total of 52% of patients were lived in an urban area, and there was no significant difference between patients and the control group regarding residency. Male patients showed low statistically significant (P 0.05) mean serum PTH, vitamin D, and calcium levels, but mean serum phosphorus and alkaline phosphatase levels were significantly higher (P 0.05) as compared to the male control group. However, female patients had low, but without statistical significant (P>0.05) mean serum PTH level, whereas vitamin D and calcium levels were highly significant (P 0.05) reduced. The phosphorus and ALP levels were highly significantly (P 0.05) increased as compared to female controls. Regarding β- thalassemia major group, the current study showed male patients had non-significant (P 0.05) higher levels of PTH, calcium, phosphorus, and ALP. In contrast, vitamin D level was non-significantly (P 0.05) low in male patients as compared to female patients. Mean serum level of PTH had a negative correlation with phosphorus, but it had a positive association with vitamin D, calcium, ALP, and magnesium. In conclusion, this study demonstrated that β-thalassemia major patients have a markedly deranged biochemical metabolic bone profile. Regular monitoring of PTH and biochemical mineral profile is also recommended.

Investigation of Biliary Canal Variations as a Cause of Stone Formation in the Choledochal Canal

2020 ◽  
Vol 2 (2) ◽  
pp. 77-85
Author(s):  
Yusuf Atakan Baltrak ◽  
M. Sabri Medişoğlu ◽  
Çolak Tuncay ◽  
Yalnız Ahmet ◽  
Çam İsa ◽  
...  
Keyword(s):  
Gall Bladder ◽  
Surgical Procedures ◽  
Stone Formation ◽  
Age Group ◽  
Female Patients ◽  
Duct Diameter ◽  
Significant Difference ◽  
Group A ◽  
Male Patients ◽  
Choledochal Duct

The present study aimed to investigate if there is an association between the diameter of the choledochal duct and choledochal duct stone formation. The present study consisted of 79 patients who had endoscopic interventions and MRCP procedure with surgery history. Some followed due to disorders of the liver, gall bladder, and biliary tract and some of whom presented hepatobiliary complaints between 2017 and 2019. The choledochal duct diameter measured from MRCP images and choledochal duct stone had examined; the type classified according to Huang classification. Among the cases classified, 29 patients, was Huang Type A1, 27 patients were Huang Type A2, 16 patients were Huang Type A3, and seven patients were Huang Type A4. There was not any statistically significant association in terms of choledochal diameter regarding the types. Choledochal duct diameter was statistically higher in female patients than male patients (p<0.05). According to the age group, a statistically significant difference detected for choledochal duct stone formation; individuals over 45 years of age present an increase for choledochal duct stone (p<0.05). The choledochal duct diameter was found higher in female patients compared with male patients; stone formation has found increased in both gender over 45 years of age. It should consider before surgical procedures and radiological tests.

Sign in / Sign up

Export Citation Format

Share Document